针对癌症免疫治疗中的替代拼接
Nan Han1,2, Zhaoqi Liu1,2
1Chinese Academy of Sciences Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China.
Frontiers in cell and developmental biology
|August 28, 2023
概括
替代拼接 (AS) 产生癌症抗原并调节免疫反应,为癌症免疫治疗提供新的途径. 器官技术通过保护瘤微环境,有助于开发这些基于拼接的免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 瘤免疫疗法面临的挑战包括有限的抗原和患者反应的变化.
- 替代拼接 (AS) 对于mRNA成熟至关重要,可以扩展癌症特异性抗原.
- AS可以调节瘤免疫性,为免疫治疗的局限性提供了潜在的解决方案.
研究的目的:
- 总结替代拼接在癌症免疫治疗中的关键作用.
- 突出器官技术在开发基于拼接的免疫疗法的好处.
- 讨论研究基于AS的免疫疗法的当前挑战.
主要方法:
- 文献综述和关于替代拼接和癌症免疫治疗的当前研究的综合.
- 讨论器官技术在这个领域的应用.
- 对生物信息学和生物技术局限性的分析.
主要成果:
- 替代拼接可以作为免疫治疗中新抗原的来源.
- 可以调节AS以用于免疫治疗向.
- AS作为指导免疫疗法选择的生物标志物.
- 机器人可以保护个体的免疫微环境,促进基于AS的免疫治疗的发展.
结论:
- 替代拼接是一种有希望的策略,可以克服癌症免疫治疗当前的局限性.
- 器官技术为推进基于拼接的免疫疗法提供了一个有价值的平台.
- 需要在生物信息学和生物技术方面取得进一步的进步,才能充分发挥基于AS的免疫疗法的潜力.
相关概念视频
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Alternative RNA Splicing
21.3K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.3K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


